Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS

NCT06488027 is registered in ClinicalTrials.gov with AB Biotek as lead sponsor.

NCT NCT06488027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS
Lead sponsor
AB Biotek
Phase
Observational
Overall status
Completed
Start date
May 5, 2023
Completion date
November 27, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, insomnia disorder